NewsBot Registered Joined 6 Aug 2002 Messages 2 Reaction score 0 23 Jun 2026 #1 Incyte Biosciences Japan Secures Japanese Approval for Minjuvi–Lenalidomide Combination in Relapsed/Refractory DLBCL BioPharma APAC Continue reading...
Incyte Biosciences Japan Secures Japanese Approval for Minjuvi–Lenalidomide Combination in Relapsed/Refractory DLBCL BioPharma APAC Continue reading...